Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3076 AL 3090

Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine

Li J, Du Q, Li N, Du S, Sun Z.

Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.

Biological Functions of Plasmalogens

Hossain MS, Mawatari S, Fujino T.

Adv Exp Med Biol. 2020;1299:171-193. doi: 10.1007/978-3-030-60204-8_13.

Alzheimer's Disease: The Unwanted Companion of Elderly

Chawla PA, Parikh V.

CNS Neurol Disord Drug Targets. 2020;19(9):646-647. doi: 10.2174/187152731909201119090829.

Advances in Drug Therapy for Alzheimer's Disease

Zhu CC, Fu SY, Chen YX, Li L, Mao RL, Wang JZ, Liu R, Liu Y, Wang XC.

Curr Med Sci. 2020 Dec;40(6):999-1008. doi: 10.1007/s11596-020-2281-2. Epub 2021 Jan 11.

Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target

Gu JL, Liu F.

Curr Med Sci. 2020 Dec;40(6):1009-1021. doi: 10.1007/s11596-020-2282-1. Epub 2021 Jan 11.

[Research progress in pharmacological effects of Erigeron breviscapus and its active ingredients for treatment of Alzheimer's disease]

Pu YZ, Su C.

Zhongguo Zhong Yao Za Zhi. 2020 Dec;45(23):5650-5657. doi: 10.19540/j.cnki.cjcmm.20200717.602.

Inflammation in Alzheimer's Disease

Fakhoury M.

Curr Alzheimer Res. 2020;17(11):959-961. doi: 10.2174/156720501711210101110513.

Alzheimer's Disease and its Related Dementia Types: A Review on Their Management Via Nanotechnology Based Therapeutic Strategies

Siafaka PI, Mutlu G, Okur NÜ.

Curr Alzheimer Res. 2020;17(14):1239-1261. doi: 10.2174/1567205018666210218160812.

CAR (Current Alzheimer Research) has a ROAD (Research on AD) Even in the Lockdown

Lahiri DK, Farlow MR.

Curr Alzheimer Res. 2020;17(12):1053-1054. doi: 10.2174/156720501712210222105659.

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease

de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G.

Front Immunol. 2021 Jan 29;11:620348. doi: 10.3389/fimmu.2020.620348. eCollection 2020.

Alzheimer's disease: exploring nature's 'medicinal chest' for new therapeutic agents

Tsarbopoulos A.

Biomol Concepts. 2020 Dec 23;11(1):201-208. doi: 10.1515/bmc-2020-0018.

Alzheimer's disease: A need for personalized therapeutic approaches

Frenkel D.

Drug Dev Res. 2020 Apr;81(2):141-143. doi: 10.1002/ddr.21652. Epub 2020 Mar 3.

Traditional Chinese medicine Danggui Shaoyao San for the treatment of Alzheimer's disease: A Protocol for Systematic Review

You Y, Liu X, You Y, Liu D, Zhang C, Chen Y, Zhang T.

Medicine (Baltimore). 2020 Apr;99(15):e19669. doi: 10.1097/MD.0000000000019669.

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Hung A, Schneider M, Lopez MH, McClellan M.

J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.

Popular three-dimensional models: Advantages for cancer, Alzheimer's and cardiovascular diseases

Ntamo Y, Samodien E, Muller CJF, Louw J, Chellan N.

Tissue Cell. 2020 Aug;65:101367. doi: 10.1016/j.tice.2020.101367. Epub 2020 Apr 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias